JPMorgan Urges Dismissal of Employee Health Plan Costs Lawsuit

June 4, 2025, 3:01 PM UTC

JPMorgan Chase & Co. defended its employee health plan from claims of high prescription drug costs, saying plan participants received all the generous benefits they were promised.

The three-month-old proposed class action should be dismissed on standing grounds because plan participants received everything they were entitled to, and thus, suffered no injury that would allow them to challenge the plan in court, JPMorgan said in a motion filed Tuesday in the US District Court for the Southern District of New York.

It’s also “wholly speculative” that these participants would have paid lower amounts had the plan been managed differently, the ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.